Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. The company offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania.

Madrigal Pharmaceuticals, Inc.

Analysts are intrested in these 5 stocks: ( ($HCA) ), ( ($THC) ), ( ($CRWV) ), ( ($MSFT) ) and ( ($MDGL) ). Here is a breakdown of their recent


	A	B	C	D
1	Symbol	Price	Change	Volume
2	MDGL	$504.85	-2.27%	20.41K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MDGL	$504.85	-2.3%	20.41K
3
4
5
6

MDGL

Get Madrigal Pharmaceuticals, Inc. Data in Excel

Get Madrigal Pharmaceuticals, Inc. Data in Excel